green tea extract polyphenone E: Clinical Trials

8 trials of green tea extract polyphenone E, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 active not recruiting, 1 recruiting. 3 Phase 3, 2 Phase 2, 2 Phase 4, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Recruiting 1
Phase 22Active not recruiting 1, Completed 1
Phase 42Completed 2
Not applicable1Completed 1
Phase 11Completed 1

Follow green tea extract polyphenone E: new trials by email Literature Review of green tea extract polyphenone E trials Research Report on green tea extract polyphenone E

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis
Topical treatment - Actinic Keratosis of Face and Scalp
Phase 3RecruitingAresus Pharma GmbH2802024-09-042025-08-22
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring
Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration - Prostate Carcinoma
Phase 2Active not recruitingECOG-ACRIN Cancer Research Group3602021-10-052026-09-04
Clinical Trial for Evaluating the Efficacy and Safety of Electrocoagulation vs Topic Sinecatechins vs Topic Cidofovir Within the Treatment to High-grade Anal Intraepithelial Neoplasia in HIV Homosexual Males
electrocoagulation, cidofovir 1% topical ointment, sinecatechins 10% topical ointment - High-grade Anal Intraepithelial Neoplasia
Phase 3CompletedHospital Universitari Vall d'Hebron Research Institute1082020-09-182024-07-10
Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study
Veregen only, Cryotherapy and Veregen - Verruca, Warts
Phase 4CompletedUniversity of Texas Southwestern Medical Center282015-07-012017-09-08
Topical Green Tea Ointment in Treatment of Superficial Skin Cancer
Sinecatechins 10%, Placebo - Carcinoma, Basal Cell
Phase 2 / Phase 3CompletedMaastricht University Medical Center422014-11-012016-05-18
Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers
Veregen, Green Tea - Anogenital Warts
Phase 1CompletedMediGene302011-12-012012-04-19
Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% Ointment
Sinecatechins 15% Ointment, Cryotherapy alone - External Genital Warts
Not applicableCompletedIcahn School of Medicine at Mount Sinai422011-09-012019-06-14
Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage
Polyphenon E (Veregen) 15% ointment, Green Tea Beverage with defined catechin content - Genital Warts, Perianal Warts
Phase 4CompletedMediGene432010-01-012010-09-08

Conditions studied

Condylomata Acuminata (2)  ·  Carcinoma, Basal Cell (1)  ·  Keratosis, Actinic (1)  ·  Prostatic Neoplasms (1)  ·  Warts (1)

Sponsors

MediGene (2)  ·  Aresus Pharma GmbH (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Maastricht University Medical Center (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

Germany (3)  ·  United States (3)  ·  Guam (1)  ·  Netherlands (1)  ·  Puerto Rico (1)  ·  Spain (1)

Top investigators

Frank Wagner, Md, PD (1)  ·  Gary Goldenberg, MD (1)  ·  Nagi B Kumar (1)  ·  Nicole WJ Kelleners-Smeets, MD, PhD (1)

Results publications

PMID 25607709, PMID 40036375

NIH funding

UG1CA189828 (1)